T Lymphocyte Development and Activation in Humanized Mouse Model
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Humanized mice, containing engrafted human cells and tissues, are emerging as an important in vivo platform for studying human diseases. Since the development of Nod scid gamma (NSG) mice bearing mutations in the IL-2 receptor gamma chain, many investigators have used NSG mice engrafted with human hematopoietic stem cells (HSCs) to generate functional human immune systems in vivo, results in high efficacy of human cell engraftment. The development of NSG mice has allowed significant advances to be made in studies on several human diseases, including cancer and graft-versus-hostdisease (GVHD), and in regenerative medicine. Based on the human HSC transplantation, organ transplantation including thymus and liver in the renal capsule has been performed. Also, immune reconstruction of cells, of the lymphoid as well as myeloid lineages, has been partly accomplished. However, crosstalk between pluripotent stem cell derived therapeutic cells with human leukocyte antigen (HLA) mis/matched types and immune CD3 T cells have not been fully addressed. To overcome this hurdle, human major histocompatibility complex (MHC) molecules, not mouse MHC molecules, are required to generate functional T cells in a humanized mouse model. Here, we briefly summarize characteristics of the humanized mouse model, focusing on development of CD3 T cells with MHC molecules. We also highlight the necessity of the humanized mouse model for the treatment of various human diseases.
Abstract
Humanized mice, containing engrafted human cells and tissues, are emerging as an important in vivo platform for studying human diseases. Since the development of Nod scid gamma (NSG) mice bearing mutations in the IL-2 receptor gamma chain, many investigators have used NSG mice engrafted with human hematopoietic stem cells (HSCs) to generate functional human immune systems in vivo, results in high efficacy of human cell engraftment. The development of NSG mice has allowed significant advances to be made in studies on several human diseases, including cancer and graft-versus-hostdisease (GVHD), and in regenerative medicine. Based on the human HSC transplantation, organ transplantation including thymus and liver in the renal capsule has been performed. Also, immune reconstruction of cells, of the lymphoid as well as myeloid lineages, has been partly accomplished. However, crosstalk between pluripotent stem cell derived therapeutic cells with human leukocyte antigen (HLA) mis/matched types and immune CD3 T cells have not been fully addressed. To overcome this hurdle, human major histocompatibility complex (MHC) molecules, not mouse MHC molecules, are required to generate functional T cells in a humanized mouse model. Here, we briefly summarize characteristics of the humanized mouse model, focusing on development of CD3 T cells with MHC molecules. We also highlight the necessity of the humanized mouse model for the treatment of various human diseases.
참고문헌 (85)
- Abedi MR, "Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells", Eur J Immunol, 22, pp.823~828 (1992)
- Andre MC, "Longterm human CD34+ stem cell-engrafted nonobese diabetic", SCID, J Immunol, pp.2010, 185[DOI]
- Billerbeck E, "Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLAtransgenic human immune system mice", J Immunol, 191, pp.1753~1764 (2013)
- Brainard DM, "Induction of robust cellular and humoral virusspecific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice", J Virol, 83, pp.7305~7321 (2009)
- Brugman MH, "Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus", Proc Natl Acad Sci USA, 112, pp.E6020~E6027 (2015)
- Bruno L, "The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells", Immunity, 5, pp.343~352 (1996)
- Cany J, "Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD", SCID, PLOS ONE, pp.2013, 8[DOI]
- Chan SH, "Another view of the selective model of thymocyte selection", Cell, 73, pp.225~236 (1993)
- Chung YS, "Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD", SCID IL2Rgammanull mice optimizes humanized mice that mount adaptive antibody responses, 2015, pp.157, 156~165
- Coleman CB, "Epstein-barr virus type 2 infects T cells and induces b cell lymphomagenesis in humanized mice", J Virol, 92, pp.e00813~e00818 (2018)
- Covassin L, "Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rgammanull (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells", Clin Exp Immunol, 174, pp.372~388 (2013)
- Danner R, "Expression of HLA class II molecules in humanized NOD.Rag1KO.IL 2RgcKO mice is critical for development and function of human T and B cells", PLOS ONE, 6, pp.e19826~ (2011)
- Davis CB, "Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes", Cell, 73, pp.237~247 (1993)
- Dessureault S, "Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model", Transplantation, 64, pp.811~816 (1997)
- Deuse T, "Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients", Nat Biotechnol, 37, pp.252~258 (2019)
- Dudek TE, "Rapid evolution of HIV-1 to functional CD8+ T cell responses in humanized BLT mice", Sci Transl Med, 4, pp.143ra98~ (2012)
- Fayard E, "Phosphatidylinositol 3-kinase signaling in thymocytes: The need for stringent control", Sci Signal, 3, pp.re5~ (2010)
- Fehling HJ, "Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells", Nature, 375, pp.795~798 (1995)
- Fitzpatrick L, "Anti-CD3-activated killer T cells: Interferongamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity", J Interferon Cytokine Res, 16, pp.537~546 (1996)
- Garcia S, "Limits of the human-PBL-SCID mice model: Severe restriction of the V beta T-cell repertoire of engrafted human T cells", Blood, 89, pp.329~336 (1997)
- Gleichmann E, "Graft-versus-host reactions: Clues to the etiopathology of a spectrum of immunological diseases", Immunol Today, 5, pp.324~332 (1984)
- Halkias J, "Opposing chemokine gradients control human thymocyte migration in situ", J Clin Invest, 123, pp.2131~2142 (2013)
- Halkias J, "Conserved and divergent aspects of human T-cell development and migration in humanized mice", Immunol Cell Biol, 93, pp.716~726 (2015)
- Henderson DA, "Role of the United States in the global response to emerging infections", J Infect Dis, 170, pp.284~285 (1994)
- Hiramatsu H, "Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD", SCID, Blood, pp.2003, 102[DOI]
- Hu Z, "Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice", Oncotarget, 7, pp.6448~6459 (2016)
- Huang M, "Improved transgenic mouse model for studying HLA class I antigen presentation", Sci Rep, 6, pp.33612~ (2016)
- Ishikawa F, "Development of functional human blood and immune systems in NOD", SCID, Blood, pp.2005, 106[DOI]
- Ito M, "NOD", SCID, Blood, pp.2002, 100[DOI]
- Jaiswal S, "Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice", Immunology, 136, pp.334~343 (2012)
- Karpel ME, "BLT humanized mice as a small animal model of HIV infection", Curr Opin Virol, 13, pp.75~80 (2015)
- Klenerman P, "T cell responses to cytomegalovirus", Nat Rev Immunol, 16, pp.367~377 (2016)
- Kooreman NG, "Alloimmune responses of humanized mice to human pluripotent stem cell therapeutics", Cell Rep, 20, pp.1978~1990 (2017)
- Kruse S, "Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model", Oncoimmunology, 8, pp.e1524694~ (2018)
- Lambolez F, "The thymus exports long-lived fully committed T cell precursors that can colonize primary lymphoid organs", Nat Immunol, 7, pp.76~82 (2006)
- Lan P, "Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus", liver and CD34+ cell transplantation, 2006, pp.108, 487~492
- Lanzavecchia A, "Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells", Science, 290, pp.92~97 (2000)
- Lapidot T, "Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice", Science, 255, pp.1137~1141 (1992)
- Lavender KJ, "BLT-humanized C57BL", 6 Rag2-, -CD47-, pp.- mice are resistant to GVHD and develop Band T-cell immunity to HIV infection, Blood[DOI]
- 이지윤, "Humanized (SCID) Mice as a Model to Study human Leukemia", 대한의생명과학회지, 21(2), pp.51~59 (2015), 대한의생명과학회[DOI]
- Lenschow DJ, "CD28", B7 system of T cell costimulation, 1996, pp.14, 233~258
- Li W, "An alternate pathway for CD4 T cell development: Thymocyte-expressed MHC class II selects a distinct T cell population", Immunity, 23, pp.375~386 (2005)
- Li Y, "A human immune system mouse model with robust lymph node development", Nat Methods, 15, pp.623~630 (2018)
- Luce S, "Humanized mouse model to study type 1 diabetes", Diabetes, 67, pp.1816~1829 (2018)
- Manz MG, "Human-hemato-lymphoid-system mice: Opportunities and challenges", Immunity, 26, pp.537~541 (2007)
- Masse-Ranson G, "Accelerated thymopoiesis and improved T-cell responses in HLA-A2", -DR2 transgenic BRGS-based human immune system mice, 2019, pp.49, 954~965
- McCune JM, "The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function", Science, 241, pp.1632~1639 (1988)
- McCune JM, "Preclinical evaluation of human hematolymphoid function in the SCID-hu mouse", Immunol Rev, 124, pp.45~62 (1991)
- Melkus MW, "Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1", Nat Med, 12, pp.1316~1322 (2006)
- Morton JJ, "Humanized mouse xenograft models: Narrowing the tumor-microenvironment gap", Cancer Res, 76, pp.6153~6158 (2016)
- Mosier DE, "Transfer of a functional human immune system to mice with severe combined immunodeficiency", Nature, 335, pp.256~259 (1988)
- Murphy KM, "The lineage decisions of helper T cells", Nat Rev Immunol, 2, pp.933~944 (2002)
- Najima Y, "Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD", SCID, Blood, pp.2016, 127[DOI]
- Niens M, "Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach", Diabetes, 60, pp.1229~1236 (2011)
- Obenaus M, "Identification of human T -cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice", Nat Biotechnol, 33, pp.402~407 (2015)
- Peault B, "Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells", J Exp Med, 174, pp.1283~1286 (1991)
- Prinz I, "Visualization of the earliest steps of gammadelta T cell development in the adult thymus", Nat Immunol, 7, pp.995~1003 (2006)
- Punt JA, "Lineage commitment in the thymus: Only the most differentiated (TCRhibcl-2hi) subset of CD4+CD8+ thymocytes has selectively terminated CD4 or CD8 synthesis", J Exp Med, 184, pp.2091~2099 (1996)
- Ridge JP, "A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell", Nature, 393, pp.474~478 (1998)
- Romero P, "Four functionally distinct populations of human effector-memory CD8+ T lymphocytes", J Immunol, 178, pp.4112~4119 (2007)
- Schoenberger SP, "T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions", Nature, 393, pp.480~483 (1998)
- Serr I, "Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice", Nat Commun, 7, pp.10991~ (2016)
- Shultz LD, "Humanized mice for immune system investigation: Progress, promise and challenges", Nat Rev Immunol, 12, pp.786~798 (2012)
- Shultz LD, "Human lymphoid and myeloid cell development in NOD", LtSz-scid IL2R gammanull mice engrafted with mobilized human hemopoietic stem cells, 2005, pp.174, 6477~6489
- Shultz LD, "Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD", SCID, Proc Natl Acad Sci USA, pp.2010, 107[DOI]
- Shultz LD, "Multiple defects in innate and adaptive immunologic function in NOD", LtSz-scid mice, 1995, pp.154, 180~191
- Smith DJ, "Propagating humanized blt mice for the study of human immunology and immunotherapy", Stem Cells Dev, 25, pp.1863~1873 (2016)
- Song J, "A mouse model for the human pathogen Salmonella typhi", Cell Host Microbe, 8, pp.369~376 (2010)
- Steinman RM, "The dendritic cell system and its role in immunogenicity", Annu Rev Immunol, 9, pp.271~296 (1991)
- Strowig T, "Priming of protective T cell responses against virus-induced tumors in mice with human immune system components", J Exp Med, 206, pp.1423~1434 (2009)
- Suzuki M, "Induction of human humoral immune responses in a novel HLA-DRexpressing transgenic NOD", Shi-scid, Int Immunol, pp.2012, 24[DOI]
- Takahama Y, "Journey through the thymus: Stromal guides for T-cell development and selection", Nat Rev Immunol, 6, pp.127~135 (2006)
- Takaki T, "HLAA*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes", J Immunol, 176, pp.3257~3265 (2006)
- Tary-Lehmann M, "Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood", J Exp Med, 175, pp.503~516 (1992)
- Tary-Lehmann M, "The human immune system in hu-PBL-SCID mice", Immunol Today, 16, pp.529~533 (1995)
- Thomas S, "Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD", SCID, Exp Hematol, pp.2014, 42[DOI]
- Traggiai E, "Development of a human adaptive immune system in cord blood celltransplanted mice", Science, 304, pp.104~107 (2004)
- Tsuchida M, "A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes", Clin Transplant, 11, pp.522~528 (1997)
- Tuckett AZ, "Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency", J Hematol Oncol, 10, pp.109~ (2017)
- Velardi E, "Sex steroid blockade enhances thymopoiesis by modulating Notch signaling", J Exp Med, 211, pp.2341~2349 (2014)
- Walsh NC, "Humanized Mouse Models of Clinical Disease", Annu Rev Pathol, 12, pp.187~215 (2017)
- Watanabe Y, "The analysis of the functions of human B and T cells in humanized NOD", shi-scid, Int Immunol, pp.2009, 21[DOI]
- Wege AK, "Functional and phenotypic characterization of the humanized BLT mouse model", Curr Top Microbiol Immunol, 324, pp.149~165 (2008)
- Williams SS, "Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies", J Immunol, 149, pp.2830~2836 (1992)
- Zakrzewski JL, "Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation", Nat Med, 12, pp.1039~1047 (2006)
